These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23912748)

  • 21. Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso.
    Somé AF; Sorgho H; Zongo I; Bazié T; Nikiéma F; Sawadogo A; Zongo M; Compaoré YD; Ouédraogo JB
    Parasite; 2016; 23():60. PubMed ID: 28004634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biological and epidemiological basis of drug resistance in malaria parasites.
    Wernsdorfer WH
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():123-9. PubMed ID: 1364857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of multi-drug resistance in Plasmodium falciparum in Thailand.
    Rooney W
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():131-7. PubMed ID: 1364859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Production of Plasmodium falciparum gametocytes: adaptation of a diabolical dissemination process of endemic malaria?].
    Robert-Gangneux F
    Sante; 1997; 7(2):146. PubMed ID: 9273122
    [No Abstract]   [Full Text] [Related]  

  • 25. Chloroquine resistant falciparum malaria--the Indian scene.
    Chogle AR
    J Assoc Physicians India; 1996 Oct; 44(10):677-8. PubMed ID: 9251337
    [No Abstract]   [Full Text] [Related]  

  • 26. High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.
    Sondén K; Wyss K; Jovel I; Vieira da Silva A; Pohanka A; Asghar M; Homann MV; Gustafsson LL; Hellgren U; Färnert A
    Clin Infect Dis; 2017 Jan; 64(2):199-206. PubMed ID: 27986683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the DELI-microtest to determine the drug sensitivity of Plasmodium falciparum in Burkina Faso.
    Moreno A; Cuzin-Ouattara N; Nebie I; Sanon S; Brasseur P; Druilhe P
    Ann Trop Med Parasitol; 2001 Apr; 95(3):309-12. PubMed ID: 11339890
    [No Abstract]   [Full Text] [Related]  

  • 28. Artemisinin resistance in Plasmodium falciparum malaria.
    Htut ZW
    N Engl J Med; 2009 Oct; 361(18):1807-8; author reply 1808. PubMed ID: 19877309
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple-Strain Malaria Infection and Its Impacts on
    Orwa TO; Mbogo RW; Luboobi LS
    Comput Math Methods Med; 2019; 2019():9783986. PubMed ID: 31341510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synchronic macrophage response and Plasmodium falciparum malaria.
    Musumeci M; Simpore J; Barone R; Angius A; Musumeci S
    J Vector Borne Dis; 2006 Jun; 43(2):84-7. PubMed ID: 16967821
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial.
    Mendes Jorge M; Ouermi L; Meissner P; Compaoré G; Coulibaly B; Nebie E; Krisam J; Klose C; Kieser M; Jahn A; Lu G; D Alessandro U; Sié A; Mockenhaupt FP; Müller O
    PLoS One; 2019; 14(10):e0222993. PubMed ID: 31600221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine-resistant malaria in Malawi.
    Muula AS
    N Engl J Med; 2007 Feb; 356(8):868-9; author reply 869. PubMed ID: 17323453
    [No Abstract]   [Full Text] [Related]  

  • 33. The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum.
    Escalante AA; Smith DL; Kim Y
    Trends Parasitol; 2009 Dec; 25(12):557-63. PubMed ID: 19864183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique.
    Hogh B; Thompson R; Hetzel C; Fleck SL; Kruse NA; Jones I; Dgedge M; Barreto J; Sinden RE
    Am J Trop Med Hyg; 1995 Jan; 52(1):50-9. PubMed ID: 7856825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum.
    Ross LS; Fidock DA
    Cell Host Microbe; 2019 Jul; 26(1):35-47. PubMed ID: 31295423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination therapy as a strategy to prevent antimalarial drug resistance].
    Orjuela P; González I; Osorio L
    Biomedica; 2004 Dec; 24(4):423-37. PubMed ID: 15678806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of chloroquine in young children with uncomplicated falciparum malaria--a community-based study in rural Burkina Faso.
    Müller O; Traoré C; Kouyaté B
    Trop Med Int Health; 2003 Mar; 8(3):202-3. PubMed ID: 12631308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoresistance in falciparum malaria.
    May J; Meyer CG
    Trends Parasitol; 2003 Oct; 19(10):432-5; discussion 435-6. PubMed ID: 14519577
    [No Abstract]   [Full Text] [Related]  

  • 39. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 40. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.